Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
The Journal of Allergy and Clinical Immunology
|
August 3, 2018
In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients
Neda Farahi, Chrystalla Loutsios, Nicola Tregay, et al.
The Journal of Allergy and Clinical Immunology
|
January 15, 2019
Reply
Neda Farahi, Chrystalla Loutsios, Nicola Tregay, et al.
Journal of Leukocyte Biology
|
April 4, 2019
Neutrophil GM-CSF receptor dynamics in acute lung injury
Silvia De Alessandris, G John Ferguson, Alison J Dodd, et al.
Frontiers in Immunology
|
December 16, 2020
Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey
Annick A J M van de Ven, Tiago M Alfaro, Alexandra Robinson, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 15, 2020
Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice
Wei Li, Lu Long, Xudong Yang, et al.
The Journal of Clinical Investigation
|
August 8, 2017
NBEAL2 is required for neutrophil and NK cell function and pathogen defense
John M Sowerby, David C Thomas, Simon Clare, et al.
The Journal of Allergy and Clinical Immunology
|
August 8, 2025
Investigating the impact of dipeptidyl peptidase-1 inhibition in humans using multi-omics
Merete B Long, Amy Gilmour, Rebecca C Hull, et al.
The Journal of Experimental Medicine
|
March 30, 2017
Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity
David C Thomas, Simon Clare, John M Sowerby, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 30, 2017
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders
John R Hurst, Nisha Verma, David Lowe, et al.
The Lancet. Respiratory Medicine
|
September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Holly R Keir, Merete B Long, Hani Abo-Leyah, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
The Journal of Allergy and Clinical Immunology
|
August 3, 2018
In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients
Neda Farahi, Chrystalla Loutsios, Nicola Tregay, et al.
The Journal of Allergy and Clinical Immunology
|
January 15, 2019
Reply
Neda Farahi, Chrystalla Loutsios, Nicola Tregay, et al.
Journal of Leukocyte Biology
|
April 4, 2019
Neutrophil GM-CSF receptor dynamics in acute lung injury
Silvia De Alessandris, G John Ferguson, Alison J Dodd, et al.
Frontiers in Immunology
|
December 16, 2020
Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey
Annick A J M van de Ven, Tiago M Alfaro, Alexandra Robinson, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 15, 2020
Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice
Wei Li, Lu Long, Xudong Yang, et al.
The Journal of Clinical Investigation
|
August 8, 2017
NBEAL2 is required for neutrophil and NK cell function and pathogen defense
John M Sowerby, David C Thomas, Simon Clare, et al.
The Journal of Allergy and Clinical Immunology
|
August 8, 2025
Investigating the impact of dipeptidyl peptidase-1 inhibition in humans using multi-omics
Merete B Long, Amy Gilmour, Rebecca C Hull, et al.
The Journal of Experimental Medicine
|
March 30, 2017
Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity
David C Thomas, Simon Clare, John M Sowerby, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 30, 2017
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders
John R Hurst, Nisha Verma, David Lowe, et al.
The Lancet. Respiratory Medicine
|
September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Holly R Keir, Merete B Long, Hani Abo-Leyah, et al.
Page
of 7